BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

747 related articles for article (PubMed ID: 8890999)

  • 1. A case of pituitary somatotroph adenoma with concomitant secretion of growth hormone, prolactin, and adrenocorticotropic hormone--an adenoma derived from primordial stem cell, studied by immunohistochemistry, in situ hybridization, and cell culture.
    Matsuno A; Sasaki T; Mochizuki T; Fujimaki T; Sanno N; Osamura Y; Teramoto A; Kirino T
    Acta Neurochir (Wien); 1996; 138(8):1002-7. PubMed ID: 8890999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pit-1 gene expression in human pituitary adenomas using the reverse transcription polymerase chain reaction method.
    Yamada S; Takahashi M; Hara M; Hattori A; Sano T; Ozawa Y; Shishiba Y; Hirata K; Usui M
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):263-72. PubMed ID: 8949563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of functional growth hormone secretagogue receptors in human pituitary adenomas: polymerase chain reaction, triple in-situ hybridization and cell culture studies.
    Barlier A; Zamora AJ; Grino M; Gunz G; Pellegrini-Bouiller I; Morange-Ramos I; Figarella-Branger D; Dufour H; Jaquet P; Enjalbert A
    J Neuroendocrinol; 1999 Jul; 11(7):491-502. PubMed ID: 10444306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone (GH) and prolactin (PRL) gene expression and immunoreactivity in GH- and PRL-producing human pituitary adenomas.
    Li J; Stefaneanu L; Kovacs K; Horvath E; Smyth HS
    Virchows Arch A Pathol Anat Histopathol; 1993; 422(3):193-201. PubMed ID: 8493775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GH and PRL gene expression by nonradioisotopic in situ hybridization in TSH-secreting pituitary adenomas.
    Sanno N; Teramoto A; Matsuno A; Takekoshi S; Osamura RY
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2518-22. PubMed ID: 7543115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free alpha-subunit and intact TSH secretion in vitro are closely associated in human somatotroph adenomas.
    Aylwin SJ; King A; Blenke A; Geddes JF; Wood DF; Monson JP; Burrin JM
    Eur J Endocrinol; 1998 Oct; 139(4):378-86. PubMed ID: 9820613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of GH, PRL, and TSH beta mRNA by transfection of Pit-1 in a human pituitary adenoma-derived cell line.
    Miyai S; Yoshimura S; Iwasaki Y; Takekoshi S; Lloyd RV; Osamura RY
    Cell Tissue Res; 2005 Nov; 322(2):269-77. PubMed ID: 16133148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycoprotein hormone genes are expressed in clinically nonfunctioning pituitary adenomas.
    Jameson JL; Klibanski A; Black PM; Zervas NT; Lindell CM; Hsu DW; Ridgway EC; Habener JF
    J Clin Invest; 1987 Nov; 80(5):1472-8. PubMed ID: 2824561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?
    Loli P; Boccardi E; Branca V; Bramerio M; Barberis M; Losa M; Terreni MT; Lodrini S; Pollo B; Vignati F
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):433-9. PubMed ID: 9876339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of growth hormone, prolactin and human beta-chorionic gonadotropin messenger RNA in growth-hormone-secreting pituitary adenomas by in situ hybridization.
    Uhlig H; Saeger W; Fehr S; Lüdecke DK
    Virchows Arch A Pathol Anat Histopathol; 1991; 418(6):539-46. PubMed ID: 2058088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical detection of glycoprotein hormone alpha subunit in somatoprolactinic and pure somatotroph adenomas.
    Vantyghem MC; Cortet C; Bauters C; Gevaert MH; Dewailly D; Lefebvre J; Mazzucca M
    J Endocrinol Invest; 1998; 21(7):434-40. PubMed ID: 9766257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of Cushing's disease caused by pituitary adenoma producing adrenocorticotropic hormone and growth hormone concomitantly: aberrant expression of transcription factors NeuroD1 and Pit-1 as a proposed mechanism.
    Tahara S; Kurotani R; Ishii Y; Sanno N; Teramoto A; Osamura RY
    Mod Pathol; 2002 Oct; 15(10):1102-5. PubMed ID: 12379758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ hybridization analysis of Pit-1 mRNA and hormonal production in human pituitary adenomas.
    Sanno N; Teramoto A; Matsuno A; Itoh J; Takekoshi S; Osamura RY
    Acta Neuropathol; 1996; 91(3):263-8. PubMed ID: 8834538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone and prolactin gene expression in human densely and sparsely granulated somatotroph adenomas by in situ hybridization with digoxigenin-labeled probes.
    Yamada S; Takahashi M; Hara M; Sano T; Aiba T; Shishiba Y; Suzuki T; Asa SL
    Diagn Mol Pathol; 1994 Mar; 3(1):46-52. PubMed ID: 8162255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of growth hormone, prolactin and human beta-chorionic gonadotropin mRNA in growth hormone-secreting pituitary adenomas and in prolactin-secreting pituitary adenomas by in situ hybridization using a non-isotopic detection method.
    Tallen G; Fehr S; Saeger W; Uhlig H; Lüdecke DK
    Acta Endocrinol (Copenh); 1993 May; 128(5):411-7. PubMed ID: 8317187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycoprotein hormone alpha-subunit production and plurihormonality in human corticotroph tumours--an in vitro and immunohistochemical study.
    Desai B; Burrin JM; Nott CA; Geddes JF; Lamb EJ; Aylwin SJ; Wood DF; Thakkar C; Monson JP
    Eur J Endocrinol; 1995 Jul; 133(1):25-32. PubMed ID: 7542980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary specific transcription factor messenger ribonucleic expression in adenomatous and nontumorous human pituitary tissues.
    Lloyd RV; Jin L; Chandler WF; Horvath E; Stefaneanu L; Kovacs K
    Lab Invest; 1993 Nov; 69(5):570-5. PubMed ID: 8246449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of Pit-1 Immunostaining in Distinguishing Pituitary Adenomas of Primitive Differentiation from Null Cell Adenomas.
    Lee JC; Pekmezci M; Lavezo JL; Vogel H; Katznelson L; Fraenkel M; Harsh G; Dulai M; Perry A; Tihan T
    Endocr Pathol; 2017 Dec; 28(4):287-292. PubMed ID: 28994039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
    Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin-3 expression in pituitary adenomas as a marker of aggressive behavior.
    Righi A; Morandi L; Leonardi E; Farnedi A; Marucci G; Sisto A; Frank G; Faustini-Fustini M; Zoli M; Mazzatenta D; Agati R; Foschini MP
    Hum Pathol; 2013 Nov; 44(11):2400-9. PubMed ID: 24007691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.